The Claim

In adults with type 2 diabetes, approximately 52% have a red blood cell lifespan shorter than 90 days, and 19% have a lifespan of 66 days or less, which suggests that underestimation of HbA1c due to reduced red blood cell survival is a common occurrence in this population.

Source: Rectify the impact of shorter red blood cell lifespan upon HbA1c detection values in T2DM patients: modeling and internal-external verification

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
42score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Quantitative
1 study reviewed
In plain English

Lots of people with type 2 diabetes have red blood cells that don’t live as long as usual, and because of that, their A1c blood sugar test might show lower numbers than reality — meaning the test could be misleading for many.

See the scientific wording

Approximately 52% of adults with type 2 diabetes have a red blood cell lifespan below 90 days, with 19% having a lifespan of 66 days or less, indicating that HbA1c underestimation due to shortened RBC survival is a common phenomenon in this population.

What the research says

1 study
  1. Study: Rectify the impact of shorter red blood cell lifespan upon HbA1c detection values in T2DM patients: modeling and internal-external verification

    The study shows that many people with type 2 diabetes have red blood cells that don't live as long, which can make their HbA1c blood sugar test readings lower than they should be—just like the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.